CLVS
Clovis Oncology, Inc.
stockNASDAQ

InactiveDec 20, 2022

0.0812USD-5.581%(-0.0048)24,516,461

Loading…

Sector

Healthcare

Industry

Biotechnology

CEO

Patrick Mahaffy

Boulder, Colorado, USA

Latest News

Oct 16, 2026

07:30 AM EDTActinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development ·

PR Newswire

CLVS Profile

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

CLVS Performance

Period	Price	Date	Change

CLVSClovis Oncology, Inc.stockNASDAQ

CLVS
Clovis Oncology, Inc.
stockNASDAQ